Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Brain-targeted enzyme-loaded nanoparticles: A breach through the blood-brain barrier for enzyme replacement therapy in Krabbe disease.

Del Grosso A, Galliani M, Angella L, Santi M, Tonazzini I, Parlanti G, Signore G, Cecchini M.

Sci Adv. 2019 Nov 20;5(11):eaax7462. doi: 10.1126/sciadv.aax7462. eCollection 2019 Nov.

2.

Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabbe disease.

Del Grosso A, Angella L, Tonazzini I, Moscardini A, Giordano N, Caleo M, Rocchiccioli S, Cecchini M.

Neurobiol Dis. 2019 Sep;129:195-207. doi: 10.1016/j.nbd.2019.05.011. Epub 2019 May 17.

PMID:
31108173
3.

Quantitative Microproteomics Based Characterization of the Central and Peripheral Nervous System of a Mouse Model of Krabbe Disease.

Pellegrini D, Del Grosso A, Angella L, Giordano N, Dilillo M, Tonazzini I, Caleo M, Cecchini M, McDonnell LA.

Mol Cell Proteomics. 2019 Jun;18(6):1227-1241. doi: 10.1074/mcp.RA118.001267. Epub 2019 Mar 29.

PMID:
30926673
4.

Cross-Linked Enzyme Aggregates as Versatile Tool for Enzyme Delivery: Application to Polymeric Nanoparticles.

Galliani M, Santi M, Del Grosso A, Cecchettini A, Santorelli FM, Hofmann SL, Lu JY, Angella L, Cecchini M, Signore G.

Bioconjug Chem. 2018 Jul 18;29(7):2225-2231. doi: 10.1021/acs.bioconjchem.8b00206. Epub 2018 Jul 2.

PMID:
29894633
5.

Lithium improves cell viability in psychosine-treated MO3.13 human oligodendrocyte cell line via autophagy activation.

Del Grosso A, Antonini S, Angella L, Tonazzini I, Signore G, Cecchini M.

J Neurosci Res. 2016 Nov;94(11):1246-60. doi: 10.1002/jnr.23910.

PMID:
27638607

Supplemental Content

Loading ...
Support Center